Clinical study to evaluate efficacy of Leuc syrup in leucorrohoea

Phase 3

Not yet recruiting

• Conditions: Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere. Ayurveda Condition: YONIROGAH/YONI-VYAPADAH,

• Registration Number: CTRI/2023/02/049887
• Lead Sponsor: Petlad Mahal Arogya Mandal Pharmacy

Brief Summary

Leucorrhoea or white discharge is a complaintwith which each woman suffers at least once in a lifetime. It refers to thewhite or yellowish discharge from the vaginal canal. The symptoms of *swetapradara* either physiological orpathological results into great discomfort and deep agony in the individuals1Leucorrhoea is found significantly more in married females as compared tounmarried, pregnant as compared to non-pregnant, and women of lowersocioeconomic status with high parity.2Symptoms of Leucorrhoea are somewhat similar to *Shwetapradara*mentioned in *Ayurvedic* literature but there is no separate chapter givenin *Brihatrayee*. Commentator *Chakrapani* has explained the word *Pandura-Asrigdara*as *Shwetapradara* in his commentary.3Taking into account theside effects and adverse effects of contemporary management , The *Ayurvedic* managementcan be recommended as a safer, feasible and effective therapy for themanagement of leucorrhoea. In this study, *Ayurveda* management by LEUCSyrup (combination of Extract of *Ashwagandha, Lodhra, Udumber, Guduchi,Vruddhadaru ; Nagakesara* ) will be carried out to evaluate the efficacy inleucorrhoea.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-03
• Last Update Posted: 2023-03-02

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

• 1.Married women having age between 18 to 55 years.
• 2.Patients having any complaint of discharge per vagina, Itching sensation at vulva, Burning sensation in vagina, Pain in vagina, Foul smell from vagina , backache and pelvic pain.

Exclusion Criteria

• 1.Female patients having pregnancy, breast feeding or post-delivery period.
• 2.Patients with any reproductive tract malignancy.
• 3.Patients with other systemic illness.
• 4.Patients with positive history of venereal diseases 5.Patients who are using CU-T or chemical method of contraception.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relieve in white discharge per vagina	at base line , 14 days

Secondary Outcome Measures

Name	Time	Method
White discharge per vagina	base line,14 days,4 weeks

Trial Locations

Locations (1)

PD Patel Ayurved Hospital attached with Js Ayurved Mahavidhyalaya; 🇮🇳 Kheda, GUJARAT, India

PD Patel Ayurved Hospital attached with Js Ayurved Mahavidhyalaya

🇮🇳Kheda, GUJARAT, India

DrNilofar Shaikh

Principal investigator

9638508994

Shaikhnilofar12@gmail.com